All Government articles – Page 61
-
BusinessUS government urged to exercise drug patent rights
Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
-
OpinionIndependent banking
Research shouldn’t be held ransom by the Spanish government in the fight over Catalonia
-
BusinessUS state passes law blocking generic drug price-gouging
Despite industry opposition, Maryland will be able to fine companies for ‘excessive and unjustified’ price increases
-
NewsCatalan independence vote fallout sees research centres’ bank accounts frozen
Spanish government seized control of regional public finances prior to the referendum and may hold them indefinitely
-
NewsNorth Korean site identified as suspected rocket fuel facility
DPRK scientific publications reveal 1,1-dimethylhydrazine production
-
NewsHome Office blunder sees materials scientist told to 'leave the UK'
Electron microscopist’s case highlights the uncertain future facing European scientists in the UK
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
BusinessUS probes opioid manufacturers
Attorneys general from 41 states will investigate companies over alleged fraudulent marketing and distribution of painkillers
-
NewsTrump’s latest immigration edict worries US research community
White House’s updated and expanded rules will harm the US’s scientific enterprise, science advocates and research universities warn
-
OpinionScientists become bedeviled advocates
Scientists need to stand up for rational thinking at a time when it is under threat around the world
-
BusinessHelium and rubber added to EU critical raw materials list
New classification sees nine materials pass threshold of supply risk, while two are downgraded
-
NewsEnergy and gene editing could be sticking points for German coalition
Merkel will have to team up with two opposing parties amid nationalist surge
-
OpinionShould individual companies be blamed for climate change?
Argument ignores consumers’ responsibility driven by our energy demands
-
NewsUS rules for ‘dual-use’ research found lacking
Regulations may overlook studies of concern and needlessly hamper other work
-
NewsScience fails to make an impact in forthcoming German elections
Researchers find election commitments to science wanting as Angela Merkel appears on course to secure a fourth term on Sunday
-
BusinessIndustry intervenes in chemical regulation lawsuits
Trade groups back up US EPA against environmental campaigners’ complaints of relaxation in new rules
-
NewsPublic record requests concern chemists
The increasing use of US freedom of information requests to obtain research grants could threaten intellectual property and innovation
-
BusinessHurricanes’ chemical consequences
Gulf coast petrochemical plants move to restart operations, while concerns persist about the fallout from hurricane Irma
-
NewsCanada invests in basic science
Government to inject half a billion dollars into fundamental research through discovery grants, scholarships and fellowships
-
BusinessFDA warns Pfizer subsidiary over Epipen malfunctions
Manufacturer did not fully investigate reports of patients dying after auto-injector failures